Financhill
Sell
46

KEQU Quote, Financials, Valuation and Earnings

Last price:
$39.50
Seasonality move :
2.62%
Day range:
$38.88 - $40.36
52-week range:
$30.33 - $71.33
Dividend yield:
0%
P/E ratio:
9.55x
P/S ratio:
0.45x
P/B ratio:
1.69x
Volume:
2.3K
Avg. volume:
10K
1-year change:
-1.27%
Market cap:
$113.2M
Revenue:
$240.5M
EPS (TTM):
$4.13

Analysts' Opinion

  • Consensus Rating
    No consensus rating exists at this time due to lack of analyst coverage.
  • Price Target Downside
    No price target exists because of limited analyst coverage.
  • Price Target Upside
    Similarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.

Fair Value

  • According to the consensus of 0 analysts, Kewaunee Scientific Corp. has -29.11% downside to fair value with a price target of -- per share.

KEQU vs. S&P 500

  • Over the past 5 trading days, Kewaunee Scientific Corp. has overperformed the S&P 500 by 5.81% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Kewaunee Scientific Corp. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Kewaunee Scientific Corp. has grown year-over-year revenues for 3 quarters straight. In the most recent quarter Kewaunee Scientific Corp. reported revenues of $71.1M.

Earnings Growth

  • Kewaunee Scientific Corp. has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Kewaunee Scientific Corp. reported earnings per share of $1.04.
Enterprise value:
170.3M
EV / Invested capital:
--
Price / LTM sales:
0.45x
EV / EBIT:
8.52x
EV / Revenue:
0.65x
PEG ratio (5yr expected):
0.09x
EV / Free cash flow:
9.10x
Price / Operating cash flow:
6.29x
Enterprise value / EBITDA:
6.68x
Gross Profit (TTM):
$77.3M
Return On Assets:
7.41%
Net Income Margin (TTM):
4.75%
Return On Equity:
19.82%
Return On Invested Capital:
10.03%
Operating Margin:
6.77%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-07-31 2024-07-31 2025-07-31 2024-07-31 2025-07-31
Income Statement
Revenue $219.2M $202.3M $263.2M $48.4M $71.1M
Gross Profit $41.3M $52.6M $77.3M $12.5M $20.9M
Operating Income $9.6M $17M $20M $2.6M $4.8M
EBITDA $12.5M $20.3M $25.5M $3.4M $6.4M
Diluted EPS $1.36 $6.23 $4.13 $0.74 $1.04
Period Ending 2021-07-31 2022-07-31 2023-07-31 2024-07-31 2025-07-31
Balance Sheet
Current Assets $62M $97.8M $93.5M $92.7M $117.1M
Total Assets $90.3M $125.6M $124.8M $132M $193.5M
Current Liabilities $36.3M $49.5M $44.2M $36.7M $50.5M
Total Liabilities $50M $90.5M $84.3M $74.5M $124.6M
Total Equity $40.3M $35.2M $40.5M $57.5M $68.9M
Total Debt $7.5M $36.6M $35.5M $33.4M $72.1M
Trailing 12 Months Fiscal Quarters
Period Ending 2023-07-31 2024-07-31 2025-07-31 2024-07-31 2025-07-31
Cash Flow Statement
Cash Flow Operations $697K $10.6M $21.4M -$794K $5.8M
Cash From Investing -$5.4M -$3M -$31.4M -$278K -$771K
Cash From Financing $4.6M -$4M $5.6M $343K -$1.5M
Free Cash Flow -$4.7M $7.6M $18.7M -$1.1M $5M
KEQU
Sector
Market Cap
$113.2M
$28.5M
Price % of 52-Week High
55.38%
51.44%
Dividend Yield
0%
0%
Shareholder Yield
-3.61%
-1.33%
1-Year Price Total Return
-1.28%
-20.32%
Beta (5-Year)
0.606
0.520
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Buy
Level $38.37
200-day SMA
Sell
Level $45.03
Bollinger Bands (100)
Sell
Level 40.4 - 54.6
Chaikin Money Flow
Buy
Level 1.6M
20-day SMA
Buy
Level $39.35
Relative Strength Index (RSI14)
Sell
Level 47.11
ADX Line
Buy
Level 13.37
Williams %R
Neutral
Level -41.6667
50-day SMA
Sell
Level $41.61
MACD (12, 26)
Sell
Level -1.05
25-day Aroon Oscillator
Sell
Level -80
On Balance Volume
Neutral
Level 2.8M

Financial Scores

Hold
Altman Z-Score (Annual)
Level (2.7789)
Buy
CA Score (Annual)
Level (-0.0393)
Sell
Beneish M-Score (Annual)
Level (-1.8631)
Buy
Momentum Score
Level (8)
Sell
Ohlson Score
Level (1.7383)
Buy
Piotroski F Score (Annual)
Level (5)
Buy
Quality Ratio Score
Level (9)
Buy
Fundamental Score
Level (9)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Kewaunee Scientific Corp. engages in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products. It operates through the following segments: Domestic, International, and Corporate. The Domestic segment designs, manufactures, and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, casework, flexible systems, work surfaces, workstations, workbenches, and computer enclosures. The International segment offers products and services, including facility design, engineering, construction, and project management from the planning stage through testing and commissioning of laboratories. The company was founded in 1906 and is headquartered in Statesville, NC.

Stock Forecast FAQ

In the current month, KEQU has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The KEQU average analyst price target in the past 3 months is --.

  • Where Will Kewaunee Scientific Corp. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Kewaunee Scientific Corp. share price will drop to -- per share over the next 12 months.

  • What Do Analysts Say About Kewaunee Scientific Corp.?

    Analysts are divided on their view about Kewaunee Scientific Corp. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Kewaunee Scientific Corp. is a Sell and believe this share price will rise from its current level to --.

  • What Is Kewaunee Scientific Corp.'s Price Target?

    The price target for Kewaunee Scientific Corp. over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is KEQU A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Kewaunee Scientific Corp. is a --. 0 of 0 analysts rate the stock a -- at this time.

  • How Can I Buy Shares Of KEQU?

    You can purchase shares of Kewaunee Scientific Corp. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Kewaunee Scientific Corp. shares.

  • What Is The Kewaunee Scientific Corp. Share Price Today?

    Kewaunee Scientific Corp. was last trading at $39.50 per share. This represents the most recent stock quote for Kewaunee Scientific Corp.. Yesterday, Kewaunee Scientific Corp. closed at $39.50 per share.

  • How To Buy Kewaunee Scientific Corp. Stock Online?

    In order to purchase Kewaunee Scientific Corp. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will Robinhood Win AI Investing?
Will Robinhood Win AI Investing?

Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Google Vs NVIDIA Stock: Which Is Best?
Google Vs NVIDIA Stock: Which Is Best?

Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
81
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Buy
56
SMX alert for Dec 6

SMX (Security Matters) Plc [SMX] is up 134.09% over the past day.

Buy
62
PRAX alert for Dec 6

Praxis Precision Medicines, Inc. [PRAX] is up 30.47% over the past day.

Sell
13
PSN alert for Dec 6

Parsons Corp. [PSN] is down 21.1% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock